Safety and tolerability of chronic intranasal oxytocin in older men: results from a randomized controlled trial

Most studies evaluating the safety and tolerability of intranasal oxytocin (OT) have not reported consistent adverse events (AEs), but they have largely focused on young men and single-dose administration. Thus, it is unclear whether these findings translate to older individuals and with longer administration periods. Extending previous work, this study investigated the safety and tolerability of chronic intranasal OT in generally healthy older...